# China NMPA Drug Inspection - Qingdao Huanghai Pharmaceutical Co., Ltd. - Nifedipine sustained-release tablets (II)

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/qingdao-huanghai-pharmaceutical-co-ltd/c7127d05-e991-45bc-b97c-1e1d2ce42956/
Source feed: China

> China NMPA drug inspection for Qingdao Huanghai Pharmaceutical Co., Ltd. published November 11, 2021. Drug: Nifedipine sustained-release tablets (II). 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 2, 2021)
- Company Name: Qingdao Huanghai Pharmaceutical Co., Ltd.
- Publication Date: 2021-11-11
- Drug Name: Nifedipine sustained-release tablets (II)
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/qingdao-huanghai-pharmaceutical-co-ltd/9d60f05f-b7ea-46a7-8133-2e64eb6b9f81/